VolitionRx Limited

AMEX: VNRX · Real-Time Price · USD
0.72
0.08 (11.84%)
At close: Aug 15, 2025, 2:36 PM

VolitionRx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.23M 775.3K 306.39K 90.03K
Cost of Revenue
n/a n/a 1.19M n/a
Gross Profit
1.23M 775.3K -882.03K 90.03K
Operating Income
-27.02M -35.99M -31.78M -28.33M
Interest Income
9.95K 93.32K 125.27K 2.73K
Pretax Income
-27.26M -35.68M -30.6M -26.99M
Net Income
-26.97M -35.32M -30.27M -26.97M
Selling & General & Admin
13.64M 16.92M 17.17M 12.75M
Research & Development
14.41M 19.55M 14.57M 15.54M
Other Expenses
n/a n/a -880.62K -1.39M
Operating Expenses
28.26M 36.76M 30.86M 26.9M
Interest Expense
340.36K 221.62K 173.09K 155.8K
Selling & Marketing Expenses
922.6K 1.01M 1.05M 4.13M
Cost & Expenses
28.26M 36.76M 30.86M 26.9M
Income Tax Expense
n/a n/a n/a -19.31K
Shares Outstanding (Basic)
86.53M 71.23M 55.35M 52.66M
Shares Outstanding (Diluted)
86.53M 71.23M 55.35M 52.66M
EPS (Basic)
-0.31 -0.5 -0.55 -0.51
EPS (Diluted)
-0.31 -0.5 -0.55 -0.51
EBITDA
-25.62M -34.04M -29.24M -25.69M
EBIT
-26.92M -35.46M -30.43M -26.83M
Depreciation & Amortization
1.34M 1.41M 1.19M 1.15M